MOLECULAR ANALYSIS OF A SERIES OF ACRAL MELANOMAS IN SINGAPORE

Size: px
Start display at page:

Download "MOLECULAR ANALYSIS OF A SERIES OF ACRAL MELANOMAS IN SINGAPORE"

Transcription

1 MOLECULAR ANALYSIS OF A SERIES OF ACRAL MELANOMAS IN SINGAPORE PoYin Tan Inny Busmanis Dept of Anatomical Pathology, Lynette Oon Head, Molecular Lab Singapore General Hospital

2 ETHNIC GROUPS IN SINGAPORE Others,.% Indian, 9.% Malay,.% Chinese, 7.% Source: Singapore Department of Statistics, 0

3 ? What is the Distribution of the Different Subtypes of Melanoma in the Singapore Population % Cutaneous 0 Acral 0 Mucosal 77 9* High % acral and mucosal subtypes * 9 cases melanoma retrieved from SGH files over year period

4 ? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 50 Caucasian 0 9 Malay Indian Others 9 Total 7

5 ? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 (%) 50 Caucasian 0 9 Malay Indian Others 9 Total 7

6 ? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 (9%) 50 Caucasian 0 9 Malay Indian Others 9 Total 7

7 ? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 50 (5%) Caucasian 0 9 Malay Indian Others 9 Total 7

8 ? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 (%) 50 Caucasian 0 9 Malay Indian Others 9 Total 7

9 ? How do Melanoma Subtypes Relate to Ethnic Groups in Singapore Ethnic Group Acral Mucosal Cutaneous Chinese 7 50 Caucasian 0 9 (%) Malay Indian Others 9 Total 7

10 Ethnic Groups Represented in the Molecular Analysis Cases (0 total) 7 Chinese (7.%) Caucasian 7 Malay Indian 5 Others Indonesian Philipino Vietnamese

11 ? What were the Categories of Melanoma According to Ethnic Group in the Molecular Cases Chinese Caucasian Malay Indian Others Cutaneous Acral 5 0 Mucosal 5 Total 0 Ranking of different types of melanoma remains the same Chinese majority in each type remains similar ; 0% skin % acral 7% mucosal Within this molecular subset the small number of Caucasians also had other tumour categories, so incidence of skin melanoma less, at 7%

12 ? What Subtypes of Melanoma are Represented in the 5 Molecular Acral Group Cases ALM Nodular 0 Desmoplastic Lymph node metastasis with no residual disease at original site 5 Of all Acral location tumours: 5 cases BRAF cases ckit

13 Molecular Results According to Histologic Subtypes of Acral Tumour Subtype BRAF ckit + + inconclusive ALM 0 5 Nodular 0 Desmoplastic No residual Total 5 Total

14 Molecular Results of Acral ALM and Nodular Subtypes Subtype BRAF ckit + + inconclusive ALM 0 5 Nodular 0 BRAF +ve cases: ALM V00E % (/) Each T>A ckit +ve cases: ALM % (5/5) Nodular 0% (/0) Each T>A? What is the Incidence of BRAF & ckit Mutations in the Exclusively Chinese Ethnic Group & ALL Acral Location Subtypes BRAF +ve ckit +ve 0% (/0) % (/) Exon x Exon x Exon 7 x

15 ? How do the BRAF & ckit Mutational Rates in Chinese, Acral Location Compare with the Mutation Status in Chinese with Cutaneous Melanoma Cutaneous: Ethnic group BRAF ckit + + Inconclusive Chinese 9 Caucasian 5 Malay Others Of ALL cutaneous cases BRAF + ve rate 55% (/) IF Caucasians excluded, BRAF +ve rate 5% (/0) Only total cases underwent ckit analysis; NIL +ve; one inconclusive

16 ? What Were the BRAF Results According to Histologic Subtypes of Cutaneous Melanoma Subtype Nodular BRAF + SSM LM Desmoplastic No residual disease 7 Note: Ckit numbers too small for analysis

17 ? So How do the Singapore Results Compare with Other Asian & Caucasian Populations As expected, a higher proportion of acral & mucosal subtypes compared with Western figures Overall incidence of ALM subtype >% BRAF +ve % ALM 5 % skin ckit +ve % ALM NIL skin Of the skin melanomas, BRAF +ve rate highest in nodular subtype ; 7 % (/) SSM ; 50 % (5/0)

18 Although there is marked difference in proportions of melanoma subtypes, molecular profiles do not appear to differ in the Singapore population, compared with Western data Other figures from Asia include BRAF +ve rate in ALM in Korea, 9. % Japan,. %.9 % palm/sole,.5 % subungual An outlier in local Asian figures is another report from Japan which cites a BRAF +ve rate in ALM of 5 %! (/0)? Technique related * laser capture microdissection & pyrosequencing

19 Thank you

Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure

Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure Comparison of Melanoma Subtypes in Korean Patients Ann Dermatol Vol. 26, No. 4, 2014 http://dx.doi.org/10.5021/ad.2014.26.4.485 ORIGINAL ARTICLE Comparison of Melanoma Subtypes among Korean Patients by

More information

Advances in Melanoma

Advances in Melanoma Advances in Melanoma The Blue, the Black and the Ugly 1 Outline History of Melanoma Why be concerned? Skin cancer updates What s old? What s new (and why are Skin Tumor Group med oncs excited again)? What

More information

Rare melanoma: Are the options improving? Dr Neil Steven Consultant in Medical Oncology University Hospital Birmingham University of Birmingham

Rare melanoma: Are the options improving? Dr Neil Steven Consultant in Medical Oncology University Hospital Birmingham University of Birmingham Rare melanoma: Are the options improving? Dr Neil Steven Consultant in Medical Oncology University Hospital Birmingham University of Birmingham Classifying melanoma Melanoma (site of origin, thickness,

More information

Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe

Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe Akita J Med 36 : 45-52, 2009 45 Katsuhiro Yamada, Natsuko Noguti, Masaaki Tsuda, Hazime Nagato, Naoko Hasunuma, Yoshihiro Umebayashi and Motomu Manabe (Received 22 December 2008, Accepted 15 January 2009)

More information

Breakthrough and Landscape of Acral and Mucosal Melanomas. Jun Guo. M.D., Ph.D Peking University Cancer Hospital & Institute

Breakthrough and Landscape of Acral and Mucosal Melanomas. Jun Guo. M.D., Ph.D Peking University Cancer Hospital & Institute Breakthrough and Landscape of Acral and Mucosal Melanomas Jun Guo. M.D., Ph.D Peking University Cancer Hospital & Institute Current status of advanced melanoma Current status of advanced MM Targeted therapy

More information

Racial differences in six major subtypes of melanoma: descriptive epidemiology

Racial differences in six major subtypes of melanoma: descriptive epidemiology Wang et al. BMC Cancer (2016) 16:691 DOI 10.1186/s12885-016-2747-6 RESEARCH ARTICLE Racial differences in six major subtypes of melanoma: descriptive epidemiology Yu Wang 1, Yinjun Zhao 2 and Shuangge

More information

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center An Overview of Melanoma Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center Melanoma Statistics Median age at presentation 45-55 55 years Incidence: 2003 54,200 cases

More information

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Concise Reference Staging and Diagnosing Cutaneous Melanoma Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Extracted from Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment Published

More information

ORIGINAL ARTICLE Cutaneous malignant melanoma: clinical and histopathological review of cases in a Malaysian tertiary referral centre

ORIGINAL ARTICLE Cutaneous malignant melanoma: clinical and histopathological review of cases in a Malaysian tertiary referral centre Malaysian J Pathol 202; (2) : 97 0 ORIGINAL ARTICLE Cutaneous malignant melanoma: clinical and histopathological review of cases in a Malaysian tertiary referral centre Jayalakshmi PAILOOR, Kein-Seong

More information

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Dermatopathology Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Melanoma and mimics Dr. Martin Mihm Malignant lesions result from the accumulation of mutations Class I lesions (benign) Class II

More information

Prediction of Lymph Node Involvement in Patients with Breast Tumors Measuring 3 5 cm in a Middle-Income Setting: the Role of CancerMath

Prediction of Lymph Node Involvement in Patients with Breast Tumors Measuring 3 5 cm in a Middle-Income Setting: the Role of CancerMath DOI 10.1007/s00268-014-2752-3 BRIEF ORIGINAL SCIENTIFIC REPORT Prediction of Lymph Node Involvement in Patients with Breast Tumors Measuring 3 5 cm in a Middle-Income Setting: the Role of CancerMath E.

More information

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU Melanoma Underwriting Presented at 2018 AHOU Conference Hank George FALU MELANOMA EPIDEMIOLOGY 70-80,000 American cases annually Majority are in situ or thin > 20% are diagnosed age 45 8-9,000 melanoma

More information

Impact of Prognostic Factors

Impact of Prognostic Factors Melanoma Prognostic Factors: where we started, where are we going? Impact of Prognostic Factors Staging Management Surgical intervention Adjuvant treatment Suraj Venna, MD Assistant Clinical Professor,

More information

Professor Michael Eccles

Professor Michael Eccles Professor Michael Eccles Developmental Genetics & Pathology Laboratory Pathology Department University of Otago Dunedin 15:00-15:15 Melanoma Metastasis and Treatment Resistance Melanoma metastasis and

More information

Epidemiology. Objectives 8/28/2017

Epidemiology. Objectives 8/28/2017 Case based Discussion of Head and Neck Melanoma: Review of Epidemiology, Risk Factors, Identification, Treatments and Prevention Jacqueline M. Doucette MS FNP-C Objectives Define and identify melanoma

More information

Metastatic Melanoma. Cynthia Kwong February 16, 2017 SUNY Downstate Medical Center Department of Surgery Grand Rounds

Metastatic Melanoma. Cynthia Kwong February 16, 2017 SUNY Downstate Medical Center Department of Surgery Grand Rounds Metastatic Melanoma Cynthia Kwong February 16, 2017 SUNY Downstate Medical Center Department of Surgery Grand Rounds Case Presentation 77 year old male with previous history of scalp melanoma and thyroid

More information

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients Annals of Oncology 28: 868 873, 2017 doi:10.1093/annonc/mdw694 Published online 30 December 2016 ORIGINAL ARTICLE The natural history and patterns of metastases from mucosal melanoma: an analysis of 706

More information

Ethnic disparities in melanoma diagnosis and survival

Ethnic disparities in melanoma diagnosis and survival Ethnic disparities in melanoma diagnosis and survival The effects of socioeconomic status and health insurance coverage Amy M. Anderson-Mellies, MPH 1 Matthew J. Rioth, MD 1,2,3 Myles G. Cockburn, PhD

More information

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD Melanoma Kaushik Mukherjee MD A. Scott Pearson MD Disclosures You still have to study Not all inclusive No Western blots Extensive use of Google Image Search and Sabiston Melanoma Basics 8 th most common

More information

What Pathology can tell us in the approach of localized colorectal cancer

What Pathology can tell us in the approach of localized colorectal cancer What Pathology can tell us in the approach of localized colorectal cancer A/Prof Tony Lim Kiat Hon Department of Anatomical Pathology Singapore General Hospital ESMO 2017 Singapore Nov 1 2 Do we still

More information

Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas

Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas The Korean Journal of Pathology 2012; 46: 246-252 ORIGINAL ARTICLE Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas Hyoun Wook Lee Ki Hoon Song 1 Jin Woo Hong 1 Su Young Jeon 1 Dong

More information

Prevalence of BRAF and NRAS Mutations and a Comparative Analysis in Primary and Metastatic Melanoma of Korean Patients

Prevalence of BRAF and NRAS Mutations and a Comparative Analysis in Primary and Metastatic Melanoma of Korean Patients Original Article Ewha Med J 2014;37(1):30-35 http://dx.doi.org/10.12771/emj.2014.37.1.30 pissn 2234-3180 eissn 2234-2591 Prevalence of BRAF and NRAS Mutations and a Comparative Analysis in Primary and

More information

Contrast with Australian Guidelines A/Pr Pascale Guitera,

Contrast with Australian Guidelines A/Pr Pascale Guitera, Contrast with Australian Guidelines A/Pr Pascale Guitera, Dermatologist, Sydney University NO CONFLICT OF INTEREST Sydney Melanoma Diagnostic Centre, RPAH 2011 2008 225 pages 16 pages http://www.cancer.org.au/file/healthprofessionals/clinica

More information

Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 124 Japanese Patients

Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 124 Japanese Patients Clinical and Pathological Features of Cutaneous Malignant Melanoma: A Retrospective Analysis of 24 Japanese Patients Yoshie Kuno, Kazuyuki Ishihara, Naoya Yamazaki and Kiyoshi Mukai 2 'Dermatology Division

More information

Rising incidence of breast cancer in Brunei Darussalam

Rising incidence of breast cancer in Brunei Darussalam Original Article Brunei Int Med J. 2011; 7 (5): 260-268 Rising incidence of breast cancer in Brunei Darussalam Vui Heng CHONG 1, Pemasari Upali TELISINGHE 2 1 Department of Medicine, and 2 Department of

More information

Enrollment Form: Pancreas

Enrollment Form: Pancreas Tissue Source Site (TSS) Name: TSS Identifier: _ TSS Unique Patient #: Completed By: Completion Date (MM/DD/YYYY): Form Notes: An Enrollment Form should be completed for each TCGA qualified case upon qualification

More information

Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 25-Year Institutional Experience

Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 25-Year Institutional Experience Virginia Commonwealth University VCU Scholars Compass Surgery Publications Dept. of Surgery 11 Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 5-Year Institutional Experience

More information

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type Primary Cutaneous Melanoma Pathology Reporting Proforma Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth DD MM YYYY Sex Male Female

More information

Acral Melanoma in Japan

Acral Melanoma in Japan Acral Melanoma in Japan MAKOTO SEUI, M.D., HIDEAKI TAKEMATSU, M.D., MICHIKO HOSOKAWA, M.D., MASAAKI OBATA, M.D., YASUSHI TOMITA, M.D., TAIZO KATO, M.D., MASAAKI TAKAHASHI, M.D., AND MARTIN C. MIHM, JR.,

More information

Your Future In Asia: Developing a market and protecting its health

Your Future In Asia: Developing a market and protecting its health Your Future In Asia: Developing a market and protecting its health Professor Jeyakumar Henry Director, Clinical Nutrition Sciences, Singapore Institute for Clinical Sciences, Professor, Department of Biochemistry,

More information

Although melanoma affects individuals from all ethnic

Although melanoma affects individuals from all ethnic Melanoma Arising in African-, Asian-, Latino- and Native-American Populations Brenda A. Shoo, MD, and Mohammed Kashani-Sabet, MD This review highlights melanoma trends observed among African-, Asian-,

More information

Living Beyond Cancer Skin Cancer Detection and Prevention

Living Beyond Cancer Skin Cancer Detection and Prevention Living Beyond Cancer Skin Cancer Detection and Prevention Cutaneous Skin Cancers Identification Diagnosis Treatment options Prevention What is the most common cancer in people? What is the most common

More information

Normal RAS-RAF (MAPK) pathway signaling

Normal RAS-RAF (MAPK) pathway signaling BRAF-Mutations in Melanomas L. Mazzucchelli Istituto Cantonale di Patologia, Locarno 77. Annual Meeting Swiss Society of Pathology, Lucerne 2011 Sponsored by Roche Pharma Switzerland Melanoma has increased

More information

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS

More information

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the

More information

MALIGNANT MELANOMA OF THE HEEL

MALIGNANT MELANOMA OF THE HEEL MALIGNANT MELANOMA OF THE HEEL Pages with reference to book, From 50 To 53 Fazli M. Qazi ( Departments of Pathology, Khyber Medical College, Peshawar. ) Rahjm Gul ( Departments of Surgery, Khyber Medical

More information

MALIGNANT MELANOMA AND OTHER MALIGNANCIES OF THE NASAL CAVITY AND THE PARANASAL SINUSES IN SWEDEN

MALIGNANT MELANOMA AND OTHER MALIGNANCIES OF THE NASAL CAVITY AND THE PARANASAL SINUSES IN SWEDEN From the Department of Oncology-Pathology, Cancer Center Karolinska, and the Department of Otorhinolaryngology, Head and Neck Surgery, Karolinska University Hospital, Karolinska Institutet, Stockholm,

More information

Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases

Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases Faruk Tas, Sidika Kurul, Hakan Camlica and Erkan Topuz Institute of Oncology, Istanbul University, Istanbul, Turkey Received

More information

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1 Skin Cancer AMERICAN OSTEOPATHIC COLLEGE OF OCCUPATIONAL & PREVENTIVE MEDICINE OMED 2012 October 8, 2012 E. Robert Wanat II, D.O., M.P.H. Learning Objectives: Identify the 3 Basic Types of Skin Cancer

More information

Index. Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, Anorectal melanoma RT for, 1035

Index. Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, Anorectal melanoma RT for, 1035 Index Note: Page numbers of article titles are in boldface type. A Age as factor in melanoma, 947 948 Anorectal melanoma RT for, 1035 B Bacille Calmette-Guerin (BCG) in melanoma, 1008 BCG. See Bacille

More information

Protocol applies to melanoma of cutaneous surfaces only.

Protocol applies to melanoma of cutaneous surfaces only. Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC

More information

Melanoma Among Blacks in the United States MaryBeth Freeman, MPH ORISE Fellow

Melanoma Among Blacks in the United States MaryBeth Freeman, MPH ORISE Fellow Melanoma Among Blacks in the United States MaryBeth Freeman, MPH ORISE Fellow NAACCR Annual Conference June 13, 2018 Data Visualizations Tool U.S. Cancer Statistics www.cdc.gov/cancer/dataviz Public Use

More information

A View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D.

A View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D. A View to the Future: Science to Survivorship Symposium September 26, 2009 The Development of Targeted Therapy for Melanoma Michael Davies, M.D., Ph.D. Assistant Professor, Melanoma Medical Oncology How

More information

Clinical and Pathologic Differences Between BRCA1-, BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country

Clinical and Pathologic Differences Between BRCA1-, BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country DOI 10.1007/s00268-009-0146-8 Clinical and Pathologic Differences Between BRCA1-, BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country Cheng-Har Yip Æ N. A. Taib Æ W. Y. Choo

More information

SUBUNGUAL MALIGNANT MELANOMA ON THE RIGHT INDEX IN A DENTIST AFTER PROLONGED OCCUPATIONAL EXPOSURE TO X-RAYS

SUBUNGUAL MALIGNANT MELANOMA ON THE RIGHT INDEX IN A DENTIST AFTER PROLONGED OCCUPATIONAL EXPOSURE TO X-RAYS SUBUNGUAL MALIGNANT MELANOMA ON THE RIGHT INDEX IN A DENTIST AFTER PROLONGED OCCUPATIONAL EXPOSURE TO X-RAYS J. HATZIS*, V. MAKROPOULOS**, N. AGNANTIS*** * Department of Skin and Venereal Diseases, University

More information

Molecular and Cellular Tumor Pathology Laboratory, Cancer Center Karolinska,

Molecular and Cellular Tumor Pathology Laboratory, Cancer Center Karolinska, Antiproliferative Effects of 1α-OH-vitD 3 in Malignant Melanoma. Potential Therapeutic implications Lucia Spath 1,+, Alessandra Ulivieri 1,4+, Luca Lavra 1,4, Laura Fidanza 2, Marta Carlesimo 2, Maria

More information

Characteristics and Treatment of Cutaneous Melanoma of the Foot

Characteristics and Treatment of Cutaneous Melanoma of the Foot Characteristics and Treatment of Cutaneous Melanoma of the Foot Kyung Wook Nam, Yong Chan Bae,, Soo Bong Nam, Joo Hyung Kim, Hoon Soo Kim, Young Jin Choi Department of Plastic and Reconstructive Surgery,

More information

Bersagli molecolari nel melanoma

Bersagli molecolari nel melanoma Bersagli molecolari nel melanoma Giuseppe Palmieri - Unit of Cancer Genetics Institute of Biomolecular Chemistry, CNR, Sassari Essential alterations in malignant cells Hanahan & Weinberg, Cell 2000 Essential

More information

Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure

Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV Exposure Meg Watson, MPH Epidemiologist NAACCR Annual Conference June 16, 2016 National Center for Chronic Disease

More information

KIT Inhibition in Advanced Melanoma: Rationale and Clinical i l Results

KIT Inhibition in Advanced Melanoma: Rationale and Clinical i l Results KIT Inhibition in Advanced Melanoma: Rationale and Clinical i l Results Richard D. Carvajal, M.D. Assistant Attending Physician Melanoma/Sarcoma Service Memorial Sloan-Kettering Cancer Center Disclosures

More information

The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterization in Stage III melanoma patients

The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterization in Stage III melanoma patients The feasibility of circulating tumour DNA as an alternative to biopsy for mutational characterization in Stage III melanoma patients ASSC Scientific Meeting 13 th October 2016 Prof Andrew Barbour UQ SOM

More information

Interesting Case Series. Desmoplastic Melanoma

Interesting Case Series. Desmoplastic Melanoma Interesting Case Series Desmoplastic Melanoma Anthony Maurice Kordahi, MD, Joshua B. Elston, MD, Ellen M. Robertson, MD, and C. Wayne Cruse, MD Division of Plastic Surgery, Department of Surgery, University

More information

Melanoma Quality Reporting

Melanoma Quality Reporting Melanoma Quality Reporting September 1, 2013 December 31, 2016 Laurence McCahill, MD Surgical Oncologist Metro Health Surgical Oncology Metro Health Professional Building 2122 Health Drive SW Wyoming,

More information

Prof. Dr. Kutikuppala Surya Rao MD.,PhD.,MNAMS.,FHM(CMC Vellore) DFM.,FCGP.,FRCP(London)

Prof. Dr. Kutikuppala Surya Rao MD.,PhD.,MNAMS.,FHM(CMC Vellore) DFM.,FCGP.,FRCP(London) A Study of HPV genotypes in HIV-Positive Women for early detection of risk for cervical cancers in Andhrapradesh, India. Prof. Dr. Kutikuppala Surya Rao MD.,PhD.,MNAMS.,FHM(CMC Vellore) DFM.,FCGP.,FRCP(London)

More information

Melanoma 6/2/2011. Classification and Prognosis. Melanoma Statistics. American Cancer Society

Melanoma 6/2/2011. Classification and Prognosis. Melanoma Statistics. American Cancer Society University of Pennsylvania, Ben Franklin in front of Charles Addams Building Melanoma Classification and Prognosis Emphasizing Pathology & History David Elder University of Pennsylvania Melanoma Statistics

More information

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13 Cotton Trade Net Exporters Africa Argentina Australia India Other Former Soviet Union Other Latin America Other Middle East Pakistan Turkey United States Uzbekistan Total Net Exports 5.01 5.62 5.62 5.66

More information

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Clinical Pathological Conference. Malignant Melanoma of the Vulva Clinical Pathological Conference Malignant Melanoma of the Vulva History F/48 Chinese Married Para 1 Presented in September 2004 Vulval mass for 2 months Associated with watery and blood stained discharge

More information

MELANOCYTIC LESIONS: EFFECTIVE MANAGEMENT IN PRIMARY CARE: Part 2

MELANOCYTIC LESIONS: EFFECTIVE MANAGEMENT IN PRIMARY CARE: Part 2 MELANOCYTIC LESIONS: EFFECTIVE MANAGEMENT IN PRIMARY CARE: Part 2 In the second part of our feature on pigmented skin lesions, dermatology specialist Dr Sweta Rai describes the steps to rational decision-making

More information

Pathology of the Thyroid

Pathology of the Thyroid Pathology of the Thyroid Thyroid Carcinoma Arising from Follicular Cells 2015-01-19 Prof. Dr. med. Katharina Glatz Pathologie Carcinomas Arising from Follicular Cells Differentiated Carcinoma Papillary

More information

CAP Laboratory Improvement Programs. Worldwide Frequency of Commonly Detected EGFR Mutations

CAP Laboratory Improvement Programs. Worldwide Frequency of Commonly Detected EGFR Mutations CAP Laboratory Improvement Programs Worldwide Frequency of Commonly Detected EGFR Mutations Rondell P. Graham, MBBS; Amanda L. Treece, MD; Neal I. Lindeman, MD; Patricia Vasalos, BS; Mu Shan, BS; Lawrence

More information

Dr Rosalie Stephens. Mr Richard Martin. Medical Oncologist Auckland City Hospital Auckland

Dr Rosalie Stephens. Mr Richard Martin. Medical Oncologist Auckland City Hospital Auckland Dr Rosalie Stephens Medical Oncologist Auckland City Hospital Auckland Mr Richard Martin General Surgeon Melanoma Unit Team Waitemata District Health Board Auckland 8:30-9:25 WS #99: Interactive Case Studies

More information

Lung Cancer Genetics: Common Mutations and How to Treat Them David J. Kwiatkowski, MD, PhD. Mount Carrigain 2/4/17

Lung Cancer Genetics: Common Mutations and How to Treat Them David J. Kwiatkowski, MD, PhD. Mount Carrigain 2/4/17 Lung Cancer Genetics: Common Mutations and How to Treat Them David J. Kwiatkowski, MD, PhD Mount Carrigain 2/4/17 Histology Adenocarcinoma: Mixed subtype, acinar, papillary, solid, micropapillary, lepidic

More information

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan

More information

Current and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian

Current and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian Current and future applications of Molecular Pathology Kathy Walsh Clinical Scientist NHS Lothian Molecular Pathology in Solid tumours Cancer type Genes tested Purpose Associated treatments Non small cell

More information

Case Report Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation

Case Report Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation Case Reports in Oncological Medicine Volume 2016, Article ID 2672671, 4 pages http://dx.doi.org/10.1155/2016/2672671 Case Report Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic

More information

Clinical Case Conference Melanoma

Clinical Case Conference Melanoma Clinical Case Conference Melanoma Epidemiology ~60,000 cases and 8,000 deaths per year in US Caucasian:African American = 10:1 15% arise from existing nevi 91% are cutaneous 15% are LN+ at presentation

More information

Horizon Scanning in Oncology

Horizon Scanning in Oncology Horizon Scanning in Oncology Ipilimumab (Yervoy ) in the adjuvant therapy for high-risk stage III cutaneous melanoma DSD: Horizon Scanning in Oncology No. 67 ISSN online 2076-5940 Horizon Scanning in

More information

Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma

Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma 1142 Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma FARUK TAS and KAYHAN ERTURK Department of Medical Oncology,

More information

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D. Cutaneous Malignancies: A Primer Marissa Heller, M.D. Associate Director of Dermatologic Surgery Department of Dermatology Beth Israel Deaconess Medical Center December 10, 2016 Skin Cancer Non-melanoma

More information

Recruiting Active; not recruiting Completed Suspended Terminated. The biological sex of the patient. Female Unknown

Recruiting Active; not recruiting Completed Suspended Terminated. The biological sex of the patient. Female Unknown Clinical Data Form Kidney Carcinoma Clinical Trial Sequencing Project Page 1 The Clinical Data Form (CDF) should be completed for every case. This form can be completed at the time the samples are submitted,

More information

Clinicopathologic Self- Assessment S003 AAD 2017

Clinicopathologic Self- Assessment S003 AAD 2017 Clinicopathologic Self- Assessment S003 AAD 2017 Clay J. Cockerell, M.D. Director, Cockerell Dermatopathology Director, Division of Dermatopathology UT Southwestern Medical Center July 2017 No relevant

More information

Melanocytic Tumours. Molecular Biology 02/06/2015. Cutaneous Melanocytic Tumours Introduction. Thomas Brenn. Intermediate Malignancy

Melanocytic Tumours. Molecular Biology 02/06/2015. Cutaneous Melanocytic Tumours Introduction. Thomas Brenn. Intermediate Malignancy Cutaneous Melanocytic Tumours Introduction Melanocytic Tumours: Update on Epidemiology and Molecular Biology Thomas Brenn Wide clinical and morphological spectrum Ranging from benign naevi to melanoma

More information

Dr. Brent Doolan, BSc MBBS MPH

Dr. Brent Doolan, BSc MBBS MPH Impact of partial biopsies on the need for complete excisional surgery in the management of cutaneous melanomas: A multi-centre review Dr. Brent Doolan, BSc MBBS MPH Peter MacCallum Cancer Centre, Melbourne

More information

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media Melanoma and Dermoscopy Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery Medical Director, University Skin Clinic University of Texas

More information

STUDY. Incidence and Survival Patterns in the United States,

STUDY. Incidence and Survival Patterns in the United States, STUDY Acral Lentiginous Melanoma Incidence and Survival Patterns in the United States, 1986-2005 Porcia T. Bradford, MD; Alisa M. Goldstein, PhD; Mary L. McMaster, MD; Margaret A. Tucker, MD Objective:

More information

Microscopically diagnosed head and neck cancers in the University Hospital, Kuala Lumpur

Microscopically diagnosed head and neck cancers in the University Hospital, Kuala Lumpur Med. J. Malaysia Vol. 44 No. 1 March 1989 Microscopically diagnosed head and neck cancers in the University Hospital, Kuala Lumpur Jayalakshmi P, MRCPath, Lecturer Pathmanathan R, MRCPath, Associate Professor

More information

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY Colorectal Cancer Structured Pathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth DD MM YYYY S1.02 Clinical details

More information

SUPPLEMENTARY APPENDIX

SUPPLEMENTARY APPENDIX SUPPLEMENTARY APPENDIX 1) Supplemental Figure 1. Histopathologic Characteristics of the Tumors in the Discovery Cohort 2) Supplemental Figure 2. Incorporation of Normal Epidermal Melanocytic Signature

More information

Demographics. 2. What was your sex at birth? If female, participant is ineligible. End of form.

Demographics. 2. What was your sex at birth? If female, participant is ineligible. End of form. Demographics (DEM) - English SCHARP SAMPLE: DO NOT FAX TO DATAFAX MTN-017 (198) DEM-1 (001) DEM-1, Page 1 of 1 Participant ID Site Number Participant Number Chk Demographics Visit Date 1. What is your

More information

Epithelial Cancer- NMSC & Melanoma

Epithelial Cancer- NMSC & Melanoma Epithelial Cancer- NMSC & Melanoma David Chin MB, BCh, BAO, LRCP, LRCS (Ireland) MCh(MD), PhD (UQ), FRCS, FRACS (Plast) Plastic & Reconstructive Surgeon Visiting Scientist Melanoma Genomic Group & Drug

More information

cmet-n375s germline mutation is associated with poor prognosis of melanoma in Chinese patients

cmet-n375s germline mutation is associated with poor prognosis of melanoma in Chinese patients Original Article cmet-n375s germline mutation is associated with poor prognosis of melanoma in Chinese patients Tian-Xiao Xu*, Si-Fan Yu*, Meng Ma, Jie Dai, Zhi-Hong Chi, Lu Si, Xi-Nan Sheng, Chuan-Liang

More information

21/07/2017. The «gray zone» of diagnosis is visible. Nevus Atypical nevus Melanoma. Melanoma ex-blue nevus

21/07/2017. The «gray zone» of diagnosis is visible. Nevus Atypical nevus Melanoma. Melanoma ex-blue nevus Update on the Clinico- Pathological and Molecular Diagnosis of Melanocytic Lesions None to declare Conflicts of interest Belfast pathology Arnaud de la Fouchardière MD, PhD Lyon, France What is new? Today

More information

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director Tumor Markers Yesterday, Today & Tomorrow Steven E. Zimmerman M.D. Vice President & Chief Medical Director Tumor Marker - Definition Substances produced by cancer cells or other cells in response to cancer

More information

ABSTRACT INTRODUCTION

ABSTRACT INTRODUCTION /, 2017, Vol. 8, (No. 9), pp: 14759-14769 Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma Cheol

More information

MAPK Pathway. CGH Next Generation Sequencing. Molecular Tools in Care of Patients with Pigmented Lesions 7/20/2017

MAPK Pathway. CGH Next Generation Sequencing. Molecular Tools in Care of Patients with Pigmented Lesions 7/20/2017 Molecular Tools in Care of Patients with Pigmented Lesions Tammie Ferringer, MD Geisinger Medical Center, Danville, PA tferringer@geisinger.edu DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Tammie Ferringer,

More information

JPRAS Open 6 (2015) 59e66. Contents lists available at ScienceDirect. JPRAS Open. journal homepage:

JPRAS Open 6 (2015) 59e66. Contents lists available at ScienceDirect. JPRAS Open. journal homepage: JPRAS Open 6 (2015) 59e66 Contents lists available at ScienceDirect JPRAS Open journal homepage: http://www.journals.elsevier.com/ jpras-open Original article Cutaneous malignant melanoma in situ: A Danish

More information

Clinico-pathological Features of Patients with Melanoma and Positive Sentinel Lymph Node Biopsy: A Single Institution Experience

Clinico-pathological Features of Patients with Melanoma and Positive Sentinel Lymph Node Biopsy: A Single Institution Experience 2015;23(2):122-129 CLINICAL ARTICLE Clinico-pathological Features of Patients with Melanoma and Positive Sentinel Lymph Node Biopsy: A Single Institution Experience Damir Homolak 1, Mirna Šitum 2,3, Hrvoje

More information

Case Report A Rare Form of Melanoma Masquerading as adiabeticfootulcer:acasereport

Case Report A Rare Form of Melanoma Masquerading as adiabeticfootulcer:acasereport Volume 2012, Article ID 502806, 4 pages doi:10.1155/2012/502806 Case Report A Rare Form of Melanoma Masquerading as adiabeticfootulcer:acasereport Susan Thomas, 1 Yuan-Xiang Meng, 1 Vijaykumar G. Patel,

More information

DISCOVERY AND VALIDATION OF PROGNOSTIC MARKERS FOR CUTANEOUS MELANOMA

DISCOVERY AND VALIDATION OF PROGNOSTIC MARKERS FOR CUTANEOUS MELANOMA From the DEPARTMENT OF ONCOLOGY-PATHOLOGY Karolinska Institutet, Stockholm, Sweden DISCOVERY AND VALIDATION OF PROGNOSTIC MARKERS FOR CUTANEOUS MELANOMA Johan Falkenius Stockholm 2018 All previously published

More information

National University Hospital, Singapore.

National University Hospital, Singapore. Characteristics and Outcomes of Paediatric and Adolescent Patients with Eating Disorders - Epidemiological Study National University Hospital, Singapore. Dr. Rajeev Ramachandran MBBS, DCH, MD, FAAP (USA),

More information

Melanoma. Walt Mudie - Block 5

Melanoma. Walt Mudie - Block 5 Melanoma Walt Mudie - Block 5 Melanoma Graphic Warning Medical names: cutaneous melanoma (melanoma of skin), intraocular melanoma (melanoma of eye) Affects mainly skin, can also affect eye, vagina or anus

More information

This online (electronic) survey contains twenty four simple questions. Those marked with an asterisk (*) must be answered.

This online (electronic) survey contains twenty four simple questions. Those marked with an asterisk (*) must be answered. 1. Type of survey This is a retrospective survey that will NOT require the disclosure of any individual patient records or data only information about overall EGFR mutation testing practices and the outcomes

More information

Mesenchymal neoplasms of the gastrointestinal tract what s new? Newton ACS Wong Department of Histopathology Bristol Royal Infirmary

Mesenchymal neoplasms of the gastrointestinal tract what s new? Newton ACS Wong Department of Histopathology Bristol Royal Infirmary Mesenchymal neoplasms of the gastrointestinal tract what s new? Newton ACS Wong Department of Histopathology Bristol Royal Infirmary Talk plan Summary from 2010 talk. What s happened since 2010. GISTs

More information

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent. Complete as narrative or use the structured format below 55752-0 17.02.28593 Clinical information 22027-7 17.02.30001 Record if different to report header Operating surgeon name and contact details 52101004

More information

- Selected Tumors of the Skin Appendages - Primary vs. Metastasis

- Selected Tumors of the Skin Appendages - Primary vs. Metastasis - Selected Tumors of the Skin Appendages - Primary vs. Metastasis Napa Valley 2018 Victor G. Prieto, MD, PhD Chair of Pathology UT MD Anderson Cancer Center vprieto@mdanderson.org Napa Valley in May Introduction

More information

Malignant Melanoma of The Skin - Still A Medical Conundrum?

Malignant Melanoma of The Skin - Still A Medical Conundrum? SCENIHR Public hearing on the Preliminary Opinion: 'Biological effects of ultraviolet radiation relevant to health with particular reference to sunbeds for cosmetic purposes. Luxembourg, April 12 th, 2016

More information

California Medicaid Enrollment and Melanoma Stage at Diagnosis A Population-Based Study

California Medicaid Enrollment and Melanoma Stage at Diagnosis A Population-Based Study California Medicaid Enrollment and Melanoma Stage at Diagnosis A Population-Based Study Ricardo A. Pollitt, PhD, Christina A. Clarke, PhD, MPH, Sarah J. Shema, MS, Susan M. Swetter, MD Background: Methods:

More information

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma Cutaneous Melanoma: Epidemiology (USA) 6 th leading cause of cancer among men and women 68,720 new cases of invasive melanoma in 2009 8,650 deaths from melanoma

More information

Meta-Analyses of Epigenetics Risk Factors for Cardiovascular Health: APOA5 Human Gene Variations Across Different Race-Ethnicity Groups

Meta-Analyses of Epigenetics Risk Factors for Cardiovascular Health: APOA5 Human Gene Variations Across Different Race-Ethnicity Groups Meta-Analyses of Epigenetics Risk Factors for Cardiovascular Health: APOA5 Human Gene Variations Across Different Race-Ethnicity Groups Yen-Chun Lin, PhD, RN, National Taiwan University Veronica Nunez,

More information